Cargando…
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the context of vaso-occlusive crisis (VOC). Although progress in the knowledge of pathophysiology of SCD have al...
Autores principales: | Federti, Enrica, Matte, Alessandro, Recchiuti, Antonio, Garello, Francesca, Ghigo, Alessandra, El Nemer, Wassim, Terreno, Enzo, Amoresano, Angela, Mattoscio, Domenico, Turrini, Franco, Lebouef, Christophe, Janin, Anne, Pantaleo, Antonella, Russo, Roberta, Marin, Mickael, Iatcencko, Iana, Riccardi, Veronica, Siciliano, Angela, Iolascon, Achille, Brugnara, Carlo, De Franceschi, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977487/ https://www.ncbi.nlm.nih.gov/pubmed/36874380 http://dx.doi.org/10.1097/HS9.0000000000000848 |
Ejemplares similares
-
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023) -
New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019) -
P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE
por: Federti, E., et al.
Publicado: (2022) -
Dietary ω-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis
por: Valenti, Maria Teresa, et al.
Publicado: (2021) -
Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells
por: Mattè, Alessandro, et al.
Publicado: (2021)